InFocus Articles
Emanuele Ostuni, Novartis Oncology
Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the…
Cell & Gene
Cell and gene therapies are fast turning into a powerful engine of value creation for drugmakers and represent a…
Big Pharma’s Quest for Blockbuster CAR-T
It has been a full three years since, first Novartis, then Gilead, took the medical world by storm by gaining FDA…
Taking Cell & Gene Mainstream
With the genomics revolution now entering full swing, expectations for the future of cell and gene therapy have…
Making CAR-T Therapy Affordable
While CAR-T therapies may well constitute the frontrunners in an amazing fresh wave of cell-based biomedical…